← Back to Search

Motivational Enhancement Therapy for Alcohol-Related Intimate Partner Violence (MET-SAH Trial)

N/A

Recruiting

Led By Casey Tyler Taft, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment, three-month, six-month, nine-month, and twelve-month follow-ups

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the effects of a brief alcohol intervention to standard care and an educational intervention in male veterans to see if it leads to reduced alcohol use and IPV perpetration.

Who is the study for?

This trial is for male Veterans at least 18 years old who are enrolled in the Strength at Home program and have alcohol-related problems. They must show evidence of these issues, like scoring high on a specific test (AUDIT), drinking heavily on occasions, or having committed IPV under the influence.

What is being tested?

The study tests if Motivational Enhancement Therapy (MET) can better reduce alcohol problems and IPV than an Alcohol Education intervention or standard phone monitoring. It's conducted with Veterans from three VA locations to see if MET also encourages seeking help for alcohol use.

What are the potential side effects?

Since this trial involves therapy and education interventions rather than medications, typical medical side effects are not expected. However, participants may experience emotional discomfort discussing sensitive topics like personal alcohol use and violent behavior.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment, three-month, six-month, nine-month, and twelve-month follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment, three-month, six-month, nine-month, and twelve-month follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment, three-month, six-month, nine-month, and twelve-month follow-ups for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Quantity/Frequency of Alcohol Consumption, Self-Report (QFV)

Secondary study objectives

Revised Conflict Tactics Scales (CTS2)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Telephone MonitoringExperimental Treatment2 Interventions

Brief supportive telephone monitoring sessions that are commonly delivered while Veterans wait to begin their groups (treatment as usual).

Group II: Motivational Enhancement TherapyExperimental Treatment2 Interventions

Motivational enhancement therapy for alcohol use problems, which includes empathic support, feedback and advice, strategies for enhancing self-efficacy, techniques for eliciting self-motivational statements from the participant, strategies for addressing participant ambivalence about change and participant resistance to change, and methods for eliciting and affirming commitment to a specific change plan (active intervention).

Group III: Alcohol Education ControlExperimental Treatment2 Interventions

Psychoeducational intervention intended to: (1) dispel myths about the effects of alcohol, (2) provide information about the general risks of drinking and process of recovery from alcohol problems, (3) provide information about the specific risks related to family relationships and IPV, (4) offer self-help program information and related strategies to address drinking problems, (5) promote and encourage healthy decision-making, and (6) reinforce the benefits of abstinence or controlled drinking.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Motivational Enhancement Therapy

2018

Completed Phase 4

~5140

Treatment as Usual

2016

Completed Phase 3

~2710